Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LYR motif-containing protein 4 (LYRM4, also known as ISD11) is an essential mitochondrial accessory protein required for the assembly of iron–sulfur (Fe–S) clusters, which are vital cofactors for numerous enzymes in energy metabolism, DNA repair, and cellular respiration. LYRM4 forms part of the mitochondrial cysteine desulfurase complex (with NFS1 and ACP), stabilizing NFS1 and modulating its cysteine desulfurase activity to enable sulfur transfer onto the ISCU scaffold protein and subsequent Fe–S cluster formation. LYRM4 is crucial for mitochondrial function and overall cellular iron homeostasis, and its dysfunction or altered expression is implicated in mitochondrial disorders and cancer, particularly liver hepatocellular carcinoma. Increased expression of LYRM4 correlates with poor prognosis in some cancers, and it may act as a potential biomarker for tumor progression and metabolic reprogramming.
Not directly drug-targeted; as an accessory protein, dysfunction or modulation could affect therapies targeting mitochondrial function, iron-sulfur metabolism, or redox biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LYR motif-containing protein 4 (LYRM4).